Orange Book product · Generic (ANDA)
MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
At a glance
Sep 25, 2008
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 25, 2008
18 yr ago
Today
Pharmaceutical detail
Active ingredient
HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
Strength
12.5MG;7.5MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 090096
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE
- 1997UNIRETICBrand (NDA)
NDA 020729 · UCB INC
- 2014MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 202150 · HERITAGE
- 2010MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 090718 · GLENMARK PHARMS
- 2007MOEXIPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDEGeneric (ANDA)
ANDA 076980 · TEVA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
